Want to see CTMX full AI Analyst Report?

CytomX Therapeutics (CTMX) Revenue

993 Followers

CytomX Therapeutics Revenue

CytomX Therapeutics had a revenue of 1.42M in the quarter ending Jun 30, 2026, with -86.18%. This bring the company's revenue in the last twelve months to 18.30M, Increased -48.51%. In the fiscal year ending Dec 31, 2025, CytomX Therapeutics had annual revenue of 76.20M with -44.82% growth.

Revenue (ttm)

18.30M

Revenue Growth

-87.03%

P/S Ratio

10.61

Revenue/Employee

$1,104,362

Employees

Market Cap

$808.41M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	76.20M	-61.90M	-44.82%
Dec 31, 2024	138.10M	36.89M	+36.45%
Dec 31, 2023	101.21M	48.05M	+90.38%
Dec 31, 2022	53.16M	15.85M	+42.48%
Dec 31, 2021	37.31M	-31.11M	-45.47%
Dec 31, 2020	68.43M	10.94M	+19.03%
Dec 31, 2019	57.49M	-2.01M	-3.38%
Dec 31, 2018	59.50M	-12.12M	-16.92%
Dec 31, 2017	71.62M	―	―